Table 2: Comparison of The Baseline Parameters in Term of The Fibrosis Severity in Liver.
Note: P values revealed the results of Kruskal Wallis test which compared all of the three groups overall, P < 0.05 was accepted as significant.
*gave the significant difference results revelaed by post hoc tests of Mann Whitney U test or Chisquaretest which compared the difference between Group 1 and 3.
¶ gave the significant difference results revelaed by post hoc tests of Mann Whitney U test or Chi-square test which compared the difference between Group 1 and 2.
# gave the significant difference results revelaed by post hoc tests of Mann Whitney U test or Chi-square test which compared the difference between Group 2 and 3.
| Groups | Group 1F, Stage 0-1 | Group 2 F, Stage 2 and 3 | Group 3 F Stage 4 and 5 | p |
| Sex(M:F) | 5/7 | 5/6 | 6/1 | 0.144 |
| Age, years old(mean±SD) | 39.8(8.5) | 45.5(14.3)¶ | 55.7(16.0)# | 0.014 |
| Serum AST(IU/L), (mean±SD) | 10(83.3%) | 10(90.9%) | 6(85.7%) | 0.868 |
| Serum ALT (IUL) (mean±SD) | 39.1±29.9 | 82.7±78.3 ¶ | 58.0±17.6 | 0.041 |
| Platelet(×103/L), (mean) | 56.2±53.4* | 126.4±113.1 ¶ | 66.8±13.3 | 0.039 |
| HBeAg(negative), N(%) | 197.363±24.700 | 163.500±44.270 | 170.285±33.700 | 0.069 |
| HBV DNA titer, mean (IU/mL) | 1.991.000* | 1.328.000 ¶ | 805.857 | 0.013 |
| MBl ng/ml, (mean/SD) | 2927±1950.5 | 2282±2304.3 | 38.08±15.21.7 | 0.310 |